These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 28823029)
1. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre. Baldi BG; Samano MN; Campos SV; de Oliveira MR; Junior JEA; Carraro RM; Teixeira RHOB; Minguini IP; Burlina R; Pato EZS; Carvalho CRR; Costa AN Lung; 2017 Dec; 195(6):699-705. PubMed ID: 28823029 [TBL] [Abstract][Full Text] [Related]
2. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis. Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137 [TBL] [Abstract][Full Text] [Related]
3. Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation? El-Chemaly S; Goldberg HJ; Glanville AR Expert Rev Respir Med; 2014 Dec; 8(6):657-60. PubMed ID: 25199529 [TBL] [Abstract][Full Text] [Related]
4. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center. Kurosaki T; Otani S; Miyoshi K; Okazaki M; Sugimoto S; Suno M; Yamane M; Kobayashi M; Oto T; Toyooka S Clin Respir J; 2020 Feb; 14(2):116-123. PubMed ID: 31729820 [TBL] [Abstract][Full Text] [Related]
5. Lung transplantation for lymphangioleiomyomatosis: the French experience. Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219 [TBL] [Abstract][Full Text] [Related]
6. Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study. Sakurai T; Kanou T; Funaki S; Fukui E; Kimura T; Ose N; Inoue Y; Shintani Y Respir Investig; 2024 Jul; 62(4):657-662. PubMed ID: 38761480 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes. Zhang J; Liu D; Yue B; Ban L; Zhou M; Wang H; Lv J; Wu B; Zhai Z; Xu KF; Chen W; Chen J Front Med (Lausanne); 2021; 8():584826. PubMed ID: 33665195 [No Abstract] [Full Text] [Related]
8. Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report. Ito T; Suno M; Sakamoto K; Yoshizaki Y; Yamamoto K; Nakanishi R; Hirano Y; Irie M; Kurosaki T; Otani S; Yamane M; Sugimoto S; Miyoshi K; Oto T Transplant Proc; 2016; 48(1):271-4. PubMed ID: 26915883 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421 [TBL] [Abstract][Full Text] [Related]
10. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241 [TBL] [Abstract][Full Text] [Related]
11. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan. Oishi H; Watanabe T; Matsuda Y; Noda M; Ejima Y; Saiki Y; Seyama K; Kondo T; Okada Y Surg Today; 2018 Oct; 48(10):944-950. PubMed ID: 29808303 [TBL] [Abstract][Full Text] [Related]
12. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant. Warrior K; Leard LE; Nair AR; Gries CJ; Fisher AJ; Johnson SR; McCormack FX; Dilling DF Respir Med; 2022; 195():106779. PubMed ID: 35276437 [TBL] [Abstract][Full Text] [Related]
13. Lung Transplantation for Lymphangioleiomyomatosis in Japan. Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M; PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878 [TBL] [Abstract][Full Text] [Related]
14. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Almoosa KF; Ryu JH; Mendez J; Huggins JT; Young LR; Sullivan EJ; Maurer J; McCormack FX; Sahn SA Chest; 2006 May; 129(5):1274-81. PubMed ID: 16685019 [TBL] [Abstract][Full Text] [Related]
15. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases]. Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation. Chen F; Omasa M; Kondo N; Fujinaga T; Shoji T; Sakai H; Bando T Ann Thorac Surg; 2009 Jan; 87(1):e6-7. PubMed ID: 19101258 [TBL] [Abstract][Full Text] [Related]
19. Lung transplantation for lymphangioleiomyomatosis: the European experience. Benden C; Rea F; Behr J; Corris PA; Reynaud-Gaubert M; Stern M; Speich R; Boehler A J Heart Lung Transplant; 2009 Jan; 28(1):1-7. PubMed ID: 19134523 [TBL] [Abstract][Full Text] [Related]
20. Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea. Chang S; Choi JS; Leem AY; Lee SH; Lee SH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Lee JG; Paik HC; Shim HS; Lee EH; Park MS Sci Rep; 2022 May; 12(1):8260. PubMed ID: 35585116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]